These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10362017)

  • 1. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
    Giri D; Ropiquet F; Ittmann M
    J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
    Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
    Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.
    Ropiquet F; Giri D; Lamb DJ; Ittmann M
    J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
    Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
    Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors.
    Wu X; Jin C; Wang F; Yu C; McKeehan WL
    Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
    Ittman M; Mansukhani A
    J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D; Ropiquet F; Ittmann M
    Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of prostatic growth and function by peptide growth factors.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
    Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2000 Jul; 157(1):249-55. PubMed ID: 10880394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
    Song Z; Powell WC; Kasahara N; van Bokhoven A; Miller GJ; Roy-Burman P
    Cancer Res; 2000 Dec; 60(23):6730-6. PubMed ID: 11118059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor (FGF) 2 and FGF9 mediate mesenchymal-epithelial interactions of peritubular and Sertoli cells in the rat testis.
    El Ramy R; Verot A; Mazaud S; Odet F; Magre S; Le Magueresse-Battistoni B
    J Endocrinol; 2005 Oct; 187(1):135-47. PubMed ID: 16214949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
    Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro.
    Duque JL; Adam RM; Mullen JS; Lin J; Richie JP; Freeman MR
    J Urol; 2001 Jan; 165(1):284-8. PubMed ID: 11125426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte growth factor expression in hormone insensitive prostate cancer.
    Leung HY; Mehta P; Gray LB; Collins AT; Robson CN; Neal DE
    Oncogene; 1997 Aug; 15(9):1115-20. PubMed ID: 9285567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.